Drug Type Small molecule drug |
Synonyms YL 18319, YL18319 |
Target |
Action inhibitors |
Mechanism PARG inhibitors(Poly(ADP-ribose) glycohydrolase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Malignant Solid Neoplasm | Phase 1 | - | 30 Oct 2026 | |
| Solid tumor | Phase 1 | China | 04 Sep 2026 | |
| Neoplasms | Preclinical | - | - | 01 Oct 2024 |





